SGLT2 inhibitors improved health status in Black and White patients with HF regardless of race.
meta_analysis · Level I
Where this comes from
- Record sourced from PubMed, PMID 37665988.
- Also identified by DOI 10.7326/J23-0071.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Gupta K, Spertus JA, Birmingham M, et al. <b>Racial differences in quality of life in patients with heart failure treated with sodium-glucose cotransporter 2 inhibitors: a patient-level meta-analysis of the CHIEF-HF, DEFINE-HF, and PRESERVED-HF trials.</b> Circulation. 2023;148:220-228. 37191040.
Medical subject headings
- Heart Failure
- Quality of Life
- Sodium-Glucose Transporter 2 Inhibitors